These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 16194404)

  • 21. Comparison of Disease Activity Score (DAS)28- erythrocyte sedimentation rate and DAS28- C-reactive protein threshold values.
    Inoue E; Yamanaka H; Hara M; Tomatsu T; Kamatani N
    Ann Rheum Dis; 2007 Mar; 66(3):407-9. PubMed ID: 16926186
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [A study on calculating the ankylosing spondylitis disease activity score according to the C-reactive protein level].
    Ji X; Du J; Zhu J; Huang F; Zhang J
    Zhonghua Nei Ke Za Zhi; 2016 Mar; 55(3):206-10. PubMed ID: 26926373
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Calculating the ankylosing spondylitis disease activity score if the conventional c-reactive protein level is below the limit of detection or if high-sensitivity c-reactive protein is used: an analysis in the DESIR cohort.
    Machado P; Navarro-Compán V; Landewé R; van Gaalen FA; Roux C; van der Heijde D
    Arthritis Rheumatol; 2015 Feb; 67(2):408-13. PubMed ID: 25332195
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CRP and ASDAS are associated with future elevated arterial stiffness, a risk marker of cardiovascular disease, in patients with ankylosing spondylitis: results after 5-year follow-up.
    Berg IJ; Semb AG; van der Heijde D; Kvien TK; Olsen IC; Dagfinrud H; Provan SA
    Ann Rheum Dis; 2015 Aug; 74(8):1562-6. PubMed ID: 25795906
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Erythrocyte sedimentation rate and C-reactive protein in the evaluation of disease activity and severity in polymyalgia rheumatica: a prospective follow-up study.
    Cantini F; Salvarani C; Olivieri I; Macchioni L; Ranzi A; Niccoli L; Padula A; Boiardi L
    Semin Arthritis Rheum; 2000 Aug; 30(1):17-24. PubMed ID: 10966209
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Protein oxidation status in patients with ankylosing spondylitis.
    Yazici C; Köse K; Calis M; Kuzugüden S; Kirnap M
    Rheumatology (Oxford); 2004 Oct; 43(10):1235-9. PubMed ID: 15292529
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Plasma phospholipid fatty acid content is related to disease activity in ankylosing spondylitis.
    Sundström B; Johansson G; Kokkonen H; Cederholm T; Wållberg-Jonsson S
    J Rheumatol; 2012 Feb; 39(2):327-33. PubMed ID: 22174215
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Performance characteristics of the simplified version of ankylosing spondylitis disease activity score (SASDAS).
    Solmaz D; Yildirim T; Avci O; Tomas N; Akar S
    Clin Rheumatol; 2016 Jul; 35(7):1753-8. PubMed ID: 26670454
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The relationship between enthesitis indices and disease activity parameters in patients with ankylosing spondylitis.
    Sivas F; Mermerci Başkan B; Erkol Inal E; Akbulut Aktekin L; Barça N; Ozoran K; Bodur H
    Clin Rheumatol; 2009 Mar; 28(3):259-64. PubMed ID: 18953622
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The clinical usefulness of ESR, CRP, and disease duration in ankylosing spondylitis: the product of these acute-phase reactants and disease duration is associated with patient's poor physical mobility.
    Chen CH; Chen HA; Liao HT; Liu CH; Tsai CY; Chou CT
    Rheumatol Int; 2015 Jul; 35(7):1263-7. PubMed ID: 25708781
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Therapeutic efficacy and safety of multiple intravenous infusions of infliximab in refractory ankylosing spondylitis patients with axial involvement.
    Rejón E; Giménez MD; Mayordomo L; Rodríguez S; González MP; Marenco JL
    Scand J Rheumatol; 2004; 33(5):323-6. PubMed ID: 15513681
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of serum interleukin-17 and interleukin-23 levels with disease activity in Chinese patients with ankylosing spondylitis.
    Chen WS; Chang YS; Lin KC; Lai CC; Wang SH; Hsiao KH; Lee HT; Chen MH; Tsai CY; Chou CT
    J Chin Med Assoc; 2012 Jul; 75(7):303-8. PubMed ID: 22824043
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum amyloid a as a useful indicator of disease activity in patients with ankylosing spondylitis.
    Jung SY; Park MC; Park YB; Lee SK
    Yonsei Med J; 2007 Apr; 48(2):218-24. PubMed ID: 17461519
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A comparative study of the usefulness of the Bath Ankylosing Spondylitis Functional Index and the Dougados Functional Index in the assessment of ankylosing spondylitis.
    Spoorenberg A; van der Heijde D; de Klerk E; Dougados M; de Vlam K; Mielants H; van der Tempel H; van der Linden S
    J Rheumatol; 1999 Apr; 26(4):961-5. PubMed ID: 10229428
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of matrix metalloproteinase-3 (MMP-3) and magnetic resonance imaging of sacroiliitis in assessing disease activity in ankylosing spondylitis.
    Soliman E; Labib W; el-Tantawi G; Hamimy A; Alhadidy A; Aldawoudy A
    Rheumatol Int; 2012 Jun; 32(6):1711-20. PubMed ID: 21431945
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bruton's Tyrosine Kinase in Ankylosing Spondylitis.
    Liao HT; Chen CH
    Spine (Phila Pa 1976); 2024 May; 49(10):677-681. PubMed ID: 37706515
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Using the Juvenile Arthritis Disease Activity Score based on erythrocyte sedimentation rate or C-reactive protein level: results from the Portuguese register.
    Mourão AF; Santos MJ; Melo-Gomes J; Martins FM; Costa JA; Ramos F; Brito I; Duarte C; Figueira R; Figueiredo G; Furtado C; Lopes A; Oliveira M; Rodrigues A; Salgado M; Sousa M; Branco JC; Fonseca JE; Canhão H
    Arthritis Care Res (Hoboken); 2014 Apr; 66(4):585-91. PubMed ID: 25354266
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum leptin levels correlate with interleukin-6 levels and disease activity in patients with ankylosing spondylitis.
    Park MC; Lee SW; Choi ST; Park YB; Lee SK
    Scand J Rheumatol; 2007; 36(2):101-6. PubMed ID: 17476615
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preliminary study of high mobility group box chromosomal protein 1(HMGB1) in ankylosing spondylitis patients.
    Chen Y; Sun W; Li S; Ni J; Su Y; Wang C; Luo X; Tu W; Shen G; Gong F; Zheng F; Dong L
    Clin Exp Rheumatol; 2015; 33(2):187-94. PubMed ID: 25602579
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fatigue in patients with ankylosing spondylitis: A comparison with the general population and associations with clinical and self-reported measures.
    Dagfinrud H; Vollestad NK; Loge JH; Kvien TK; Mengshoel AM
    Arthritis Rheum; 2005 Feb; 53(1):5-11. PubMed ID: 15696569
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.